About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3800634
Allelic
Composition
Tg(CAMalpha1b)7Wjk/?
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(CAMalpha1b)7Wjk mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• the heart to body weight ratio is increased by 20% compared to non-transgenic controls
• approximate 2.5-fold increase in heart weight, suggesting eccentric cardiac hypertrophy in the late stages of cardiomyopathy
• myocytes located in the right ventricle have a 62% higher cross-section than found in non-transgenic controls

mortality/aging
• average age of death is 8.6 +/- 0.7 months
• males survive longer than females, dying on average at 12.4 months compared to 7 months for females

cardiovascular system
N
• systolic and diastolic blood pressure is normal in these mice
• heart muscle contains elevated levels of diacylglycerol resulting from enhanced signaling by the alpha 1 adrenergic receptor through the Gq-phospholipase C-protein kinase C signaling pathway
• left ventricular walls exhibit myofibrillar disarray
• distortion of both ventricles
• the heart to body weight ratio is increased by 20% compared to non-transgenic controls
• approximate 2.5-fold increase in heart weight, suggesting eccentric cardiac hypertrophy in the late stages of cardiomyopathy
• myocytes located in the right ventricle have a 62% higher cross-section than found in non-transgenic controls
• left ventricular end-systolic area and left ventricular end-diastolic area are higher at 6 and 9 months of age but not at 3 months, indicating progressive left ventricle enlargement with age
• all 4 cardiac chambers are enlarged
• however, posterior and septum wall thickness are largely unchanged
• mice exhibit late-onset dilated cardiomyopathy
• fractional area change is decreased between 3 and 9 months of age by about 20%, indicating loss in left ventricular systolic function
• left ventricular end-systolic area and left ventricular end-diastolic area are higher at 6 and 9 months of age but not at 3 months, indicating progressive left ventricle enlargement with age
• left ventricular end-systolic area is increased over 80% from 3 to 9 months of age
• fractional area change is decreased between 3 and 9 months of age by about 20%
• mice present with signs of heart failure, including fatigue and dyspnea, followed by generalized edema and death

homeostasis/metabolism
• frequent presence of right atrial thrombus
• seen before mice die

muscle
• heart muscle contains elevated levels of diacylglycerol resulting from enhanced signaling by the alpha 1 adrenergic receptor through the Gq-phospholipase C-protein kinase C signaling pathway
• left ventricular walls exhibit myofibrillar disarray
• myocytes located in the right ventricle have a 62% higher cross-section than found in non-transgenic controls
• mice exhibit late-onset dilated cardiomyopathy
• fractional area change is decreased between 3 and 9 months of age by about 20%, indicating loss in left ventricular systolic function

respiratory system
• seen before mice die

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
dilated cardiomyopathy DOID:12930 OMIM:PS115200
J:134704


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory